![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Dolutegravir Monotherapy in HIV-infected Patients with
Sustained Viral Suppression: A 24-week Pilot Study
|
|
|
Reported by Jules Levin
EACS 2015 Oct 21-4 Barcelona, Spain - 15th European AIDS Conference
Jhon Rojas1, Jose L Blanco1, Montserrat Lonca1, Berta Torres1, Marta Parera1, Ana Gonzalez1, Josep Mallolas1, Amparo Tricas1, Laura Moreno1,
Federico Garcia2, Jose M Gatell1, and Esteban Martinez1.
1Hospital Clinic, University of Barcelona, Barcelona, Spain; and 2Hospital Universitario San Cecilio, Granada, Spain.
![EACS1.gif](../images/102715/102715-5/EACS1.gif)
![EACS2.gif](../images/102715/102715-5/EACS2.gif)
![EACS3.gif](../images/102715/102715-5/EACS3.gif)
![EACS4.gif](../images/102715/102715-5/EACS4.gif)
![EACS5.gif](../images/102715/102715-5/EACS5.gif)
![EACS6.gif](../images/102715/102715-5/EACS6.gif)
![EACS7.gif](../images/102715/102715-5/EACS7.gif)
![EACS8.gif](../images/102715/102715-5/EACS8.gif)
![EACS9.gif](../images/102715/102715-5/EACS9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|